Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer

Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, Widmann WD. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 19, 217–224, 2012.10.1245/s10434-011-1814-021638095Search in Google Scholar

Chen Q, Yang LX, Li XD, Yin D, Shi SM, Chen EB, Yu L, Zhou ZJ, Zhou SL, Shi YH, Fan J, Zhou J, Dai Z. The elevated preoperative neutrophil-to-lmyphocyte ration predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy. Tumour Biol 36, 5283–5289, 2015.10.1007/s13277-015-3188-625672606Search in Google Scholar

Coussens LM, Werb Z. Inflammation and cancer. Nature 420, 860–867, 2002.10.1038/nature01322280303512490959Search in Google Scholar

Duzlu M, Karamert R, Tutar H, Karaloglu F, Sahin M, Cevizci R. Neutrophil-lymphocyte ratio findings and larynx carcinoma: a preliminary study in Turkey. Asian Pac J Cancer Prev 16, 351–354, 2015.10.7314/APJCP.2015.16.1.351Search in Google Scholar

Forget P, Dinant V, De Kock M. Is the neutrophil-to-lymphocyte ratio more correlated than C-reactive protein with postoperative complications after major abdominal surgery? Peer J 3, e713, 2015.10.7717/peerj.713430485425653901Search in Google Scholar

Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88, 218–230, 2013.10.1016/j.critrevonc.2013.03.01023602134Search in Google Scholar

Ji WH, Jiang YH, Ji YL, Mao WM. Prechemotherapy neutrophil: lymphocyte ratio is superior to the platelet: lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy. Dis Esophagus 29, 403–411, 2016.10.1111/dote.1232225625421Search in Google Scholar

Jung MR, Park YK, Jeong O, Seon JW, Ryu SY, Kim DY, Kim YJ. Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol 104, 504–510, 2011.10.1002/jso.2198621618251Search in Google Scholar

Kim JY, Park T, Jeong SH, Jeong CY, Ju YT, Lee YJ, Hong SC, Ha WS, Choi SK, Jung EJ. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine 46, 526–531, 2014.10.1007/s12020-013-0089-624272600Search in Google Scholar

Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 16, 614–622, 2009.10.1245/s10434-008-0267-619130139Search in Google Scholar

Lang B, Lo CY, Chan WF, Lam KY, Wan KY. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability. Ann Surg Oncol 14, 1551–1559, 2007.10.1245/s10434-006-9242-217318278Search in Google Scholar

Lang BH, Ng CP, Au KB, Wong KP, Wong KK, Wan KY. Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma? World J Surg 38, 2605–2612, 2014.10.1007/s00268-014-2630-z24809487Search in Google Scholar

Langsenlehner T, Thurner EM, Krenn-Piko S, Langsenlehner U, Stojakovic T, Gerger A, Pichler M. Validation of the neutrophil-to-lymphocyte ration as a prognostic factor in an cohort of European prostate cancer patients. World J Urol 33, 1661–1667, 2015.10.1007/s00345-015-1494-725617235Search in Google Scholar

Liu CL, Lee JJ, Liu TP, Chang YC, Hsu YC, Cheng SP. Blood neutrophil-to-lymphocyte ration correlates with tumor size in patients with differentiated thyroid cancer. J Surg Oncol 107, 493–497, 2013.10.1002/jso.2327022996403Search in Google Scholar

McMillan DC. The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev 39, 534–540, 2013.10.1016/j.ctrv.2012.08.00322995477Search in Google Scholar

Nozawa H, Chiu C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103, 12493–12498, 2006.10.1073/pnas.0601807103153164616891410Search in Google Scholar

Okamura Y, Ashida R, Ito T, Sugiura T, Mori K, Uesaka K. Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepaticellular carcinoma. World J Surg 39, 1501–1509, 2015.10.1007/s00268-015-2982-z25670038Search in Google Scholar

Seretis C, Gourgiotis S, Gemenetzis G, Seretis F, Lagoudianakis E, Dimitrakopoulos G. The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinoma in thyroidal goiters: a pilot study. Am J Surg 205, 691–696, 2013.10.1016/j.amjsurg.2012.08.00623388425Search in Google Scholar

Song Y, Liu H, Gao L, Liu X, Ma L, Lu M, Gao Z. Preoperative neutrophil-to-lymphocyte ratio as prognostic predictor for hypopharyngeal squamous cell carcinoma after radical resections. J Craniofac Surg 26, e137–e140, 2015.10.1097/SCS.000000000000123525643330Search in Google Scholar

Szkandera J, Gerger A, Liegl-Atzwanger B, Stotz M, Samonigg H, Friesenbichler J, Stojakovic T, Leithner A, Pichler M. The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients. Am J Surg 210, 111–116, 2015.10.1016/j.amjsurg.2014.10.02125586599Search in Google Scholar

Turkmen K, Erdur FM, Ozcicek F, Ozcicek A, Akbas EM, Ozbicer A, Demirtas L, Turk S, Tonbul HZ. Platelet-to-lymphocyte ration better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int 17, 391–396, 2013.10.1111/hdi.1204023522328Search in Google Scholar

Tuttle RM. Differentiated thyroid cancer: Overview of management. UpToDate, Wolters Kluwer (Eds. Ross DS, Mulder JE), 2017.Search in Google Scholar

Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neuthrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91, 181–184, 2005.10.1002/jso.2032916118772Search in Google Scholar

Wang S, Zhang Z, Fang F, Gao X, Sun W, Liu H. The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. Oncol Lett 2, 735–740, 2011.10.3892/ol.2011.304340633722848258Search in Google Scholar

Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene 27, 5904–5912, 2008.10.1038/onc.2008.271368926718836471Search in Google Scholar